Valvular & structural heart diseaseCohort study
Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry
- Retrospective cohort study
- international registry
- multicentre
- consecutive patients
Authors' conclusion
Patients were often referred late in the disease process, with few patients undergoing early intervention.
Study context
- Population
- Consecutive adults undergoing isolated or combined mitral valve surgery for mitral regurgitation (MR) in France or Canada in 2019
- Participants
- 3,522 adults · 40 centres
Main finding
As reported in the abstract
Repair rate and in-hospital mortality after MVS for MR · in-hospital
- Repair rate, overall
- 62%
- Repair rate, myxomatous disease
- 80%
- In-hospital mortality, overall
- 4.5%
- In-hospital mortality, myxomatous MR
- 2.3%
- In-hospital mortality, myxomatous MR, isolated mitral valve surgery (MVS)
- 1.8%
- In-hospital mortality, myxomatous MR, combined MVS
- 3.1%
Observational data: associations, not effects.
Original publication
Clinical Presentation and Outcomes After Surgery for Mitral Regurgitation: Real-World Insights From the MITRACURE International Registry. Circulation. Published 31 August 2025. doi:10.1161/circulationaha.124.073674
Summarised from the published abstract; every number is checked against it